[Therapy of shock].
D000138:Acidosis / Q000517:prevention & control; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001803:Blood Transfusion; D001809:Blood Viscosity; D002301:Cardiac Glycosides / Q000627:therapeutic use; D003102:Colloids; D006801:Humans; D010101:Oxygen Consumption; D010952:Plasma Substitutes / Q000627:therapeutic use; D010953:Plasma Volume; D012769:Shock / Q000628:therapy*; D012770:Shock, Cardiogenic / Q000188:drug therapy; D012771:Shock, Hemorrhagic / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D000925:Anticoagulants; D002301:Cardiac Glycosides; D003102:Colloids; D010952:Plasma Substitutes
Schock--behandlung.